Oculis Holding AG
OCSHealthcare|Biotechnology|CH
$7.49
+0.66 (+9.66%)
DCF Value
$1.82
Tangible Book / Share
$3.39
Cash / Share
$0.00
Clinical Trials (11)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07548632 A Clinical Study Evaluating Licaminlimab for Dry Eye Disease | Dry Eye Disease (DED) | P2P3 | Active | 160 | RCT, Double-blind | licaminlimab |
| NCT07623668 Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research | Optic Neuritis | P3 | Recruiting | 210 | RCT, Double-blind | Privosegtor, Methylprednisolone |
| NCT05608837 Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema | Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative | P2 | Active | 28 | RCT, Double-blind | OCS-01 |
| NCT06128369 A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery | Inflammation Eye Pain, Postoperative Cataract | P3 | Terminated | 117 | RCT, Double-blind | OCS-01, Vehicle |
| NCT05147233 A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery | Inflammation Eye Pain, Postoperative Cataract | P3 | Completed | 241 | RCT, Double-blind | OCS-01, Vehicle |
| NCT05066997 A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1) | Diabetic Macular Edema | P2P3 | Completed | 552 | RCT, Double-blind | Dexamethasone ophthalmic suspension (OCS-01), Vehicle |
| NCT06172257 A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) | Diabetic Macular Edema | P3 | Completed | 401 | RCT, Double-blind | Dexamethasone ophthalmic suspension (OCS-01), Vehicle |
| NCT04130802 OCS-01 in Treating Inflammation and Pain in Post-cataract Patients | Inflammation Corneal, Pain, Postoperative | P2 | Completed | 153 | RCT, Double-blind | OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL, Placebo |
| NCT05896670 Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease | Dry Eye Disease | P2 | Completed | 122 | RCT, Double-blind | licaminlimab |
| NCT04762017 OCS-05 in Patients With Optic Neuritis | Optic Neuritis | P2 | Completed | 36 | RCT, Double-blind | OCS-05 +SoC (corticosteroid) IV administration |
| NCT05343156 Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema | Diabetic Macular Edema | P2 | Completed | 144 | RCT, Double-blind | Dexamethasone nanoparticles eye drops |